ClassID:

94123

C07D209/60 - CPC Classification

Classification description:

Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom; Ring systems containing three or more rings [b]- or [c]-condensed Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles

Recent Application in this class:
#1
20260103443
2026-04-16

CHEMICAL COMPOUND

#2
20260028482
2026-01-29

Substitution at the Central Position of Heptamethine Dyes By Aryllithium Addition for Improved Fluorophores

#3
20250189532
2025-06-12

1,6-DIYNE COMPOUND, ITS PREPARATION METHOD, AND PRODUCTS OBTAINED USING 1,6-DIYNE COMPOUND AS RAW MATERIAL AND THEIR APPLICATIONS

#4
20250034090
2025-01-30

NOVEL S1P1 RECEPTOR AGONIST, CRYSTALLINE SALTS, PROCESSES FOR PREPARING, AND USES RELATED THERETO

#5
20240279176
2024-08-22

SUBSTITUTED TRICYCLIC HETEROCYCLIC COMPOUNDS AS METALLO-BETA-LACTAMASE INHIBITORS

#6
20240199547
2024-06-20

OPTICAL ABSORBENT COMPOSITION

#7
20240158639
2024-05-16

PROCESS FOR PREPARING INDOCYANINE GREEN

#8
20240148694
2024-05-09

TREATMENT OF ANDROGEN DEPRIVATION THERAPY ASSOCIATED SYMPTOMS

#9
20230295087
2023-09-21

AGONISTS OF ROR GAMMAt

#10
20230174479
2023-06-08

CYANINE-DERIVED COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

#11
20230131121
2023-04-27

BRANCHED DISCRETE PEG CONSTRUCTS

#12
20230100211
2023-03-30

PROCESS FOR THE PREPARATION OF SODIUM 4-(2-((1E,3E,5E,7Z)-7-(1,1-DIMETHYL-3-(4-SULFONATOBUTYL)-1H-BENZO[e]INDOL-2(3H)-YLIDENE) HEPTA-1,3,5-TRIENYL)-1,1-DIMETHYL-1H-BENZO[e]INDOLIUM-3-YL) BUTANE-1-SULFONATE (INDOCYANINE GREEN)

#13
20220267268
2022-08-25

NEW TRICYCLIC 5-HT2 ANTAGONISTS

#14
20220155310
2022-05-19

WATER-SOLUBLE COMPOUND FOR DETECTION OF BETA-AMYLOID

#15
20220048859
2022-02-17

Synthetic process

#16
20220023277
2022-01-27

Carbonic anhydrase targeting agents and methods of using same

#17
20220008386
2022-01-13

Tosylacetate based compounds and derivatives thereof as PHGDH inhibitors

#18
20200390744
2020-12-17

TREATMENT OF ANDROGEN DEPRIVATION THERAPY ASSOCIATED SYMPTOMS

#19
20200386930
2020-12-10

OPTICALLY FUNCTIONAL FILM

#20
20200369889
2020-11-26

Squarylium compounds for use in display devices

#21
20200331892
2020-10-22

Compound and optical filter and image sensor and camera module and electronic device

#22
20200317612
2020-10-08

Branched Discrete PEG Constructs

#23
20200172484
2020-06-04

Method for the synthesis of monoprotected bifunctional prodrugs and antibody drug conjugates based thereon as well as a method for preparing antibody drug conjugates

#24
20200116896
2020-04-16

Composition, film, lens, solid state imaging element, and compounds

#25
20190365931
2019-12-05

Double-labeled probe for molecular imaging and use thereof

#26
20190337896
2019-11-07

PROCESS FOR THE PREPARATION OF SODIUM 4-(2-((1E,3E,5E,7Z)-7-(1,1-DIMETHYL-3-(4-SULFONATOBUTYL)-1H-BENZO[e]INDOL-2(3H)-YLIDENE) HEPTA-1,3,5-TRIENYL)-1,1-DIMETHYL-1H-BENZO[e]INDOLIUM-3-YL) BUTANE-1-SULFONATE (INDOCYANINE GREEN)

#27
20190300501
2019-10-03

Carbonic anhydrase targeting agents and methods of using same

#28
20190241588
2019-08-08

Tricyclic sulfones as RORγ modulators

#29
20190233374
2019-08-01

Tricyclic sulfones as RORmodulators

#30
20190119316
2019-04-25

NEW NUCLEOPHILE-REACTIVE SULFONATED COMPOUNDS FOR THE (RADIO)LABELLING OF (BIO)MOLECULES; PRECURSORS AND CONJUGATES THEREOF

#31
20190111039
2019-04-18

Treatment of androgen deprivation therapy associated symptoms

#32
20190106448
2019-04-11

Manganese (III) catalyzed C—H aminations

#33
20180327357
2018-11-15

Organic compound, near-infrared fluorescent constant medium containing same, and method for nano-granulating constant medium

#34
20180311212
2018-11-01

Bifunctional prodrugs

#35
20180303797
2018-10-25

Chalcone compounds

#36
20180134689
2018-05-17

Benzocyanine compounds

#37
20180002358
2018-01-04

Tricyclic sulfones as RORγ modulators

#38
20170354747
2017-12-14

Cyanine-containing compounds for cancer imaging and treatment

#39
20170335182
2017-11-23

Compound and contrast agent for optical imaging having the compound

#40
20170313656
2017-11-02

Branched discrete PEG constructs

#41
20170172992
2017-06-22

Treatment of androgen deprivation therapy associated symptoms

#42
20170166575
2017-06-15

Oxime ester compound and photopolymerization initiator containing said compound

#43
20170158731
2017-06-08

Nucleophile-reactive sulfonated compounds for the (radio)labelling of (bio)molecules; precursors and conjugates thereof

#44
20170145006
2017-05-25

Process for making duocarmycin prodrugs

#45
20160326195
2016-11-10

Tricyclic sulfones as RORγ modulators

#46
20160318865
2016-11-03

Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors

#47
20160268517
2016-09-15

Biscarbazole derivative and organic electroluminescent element using same

#48
20160259242
2016-09-08

Onium salt compound, resist composition, and pattern forming process

#49
20160222211
2016-08-04

Fluorescent probe for imaging lymph nodes

#50
20160122813
2016-05-05

Methods and kits using extended rhodamine dyes

#51
20160052880
2016-02-25

CC-1065 analogs and their conjugates

#52
20160002229
2016-01-07

Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors

#53
20150335745
2015-11-26

Halogenated compounds for photodynamic therapy

#54
20150329490
2015-11-19

Cyanine dye compound and preparation method therefor, and dual-function agent for photodynamic therapy and preparation method therefor

#55
20150284326
2015-10-08

Nucleophile-reactive sulfonated compounds for the (radio)labelling of (bio) molecules; precursors and conjugates thereof

#56
20150249219
2015-09-03

Biscarbazole derivative and organic electroluminescent element using same

#57
20150218380
2015-08-06

Modified carbocyanine dyes and their conjugates

#58
20150171347
2015-06-18

Dibenzole[]carbazole compound, light-emitting element, light-emitting device, display device, lighting device and electronic device

#59
20150167073
2015-06-18

Polymethine compounds and their use as fluorescent labels

#60
20150165063
2015-06-18

1-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatment

#61
20150157741
2015-06-11

Compound and photoacoustic imaging contrast medium containing the compound

#62
20150110715
2015-04-23

Double-labeled probe for molecular imaging and use thereof

#63
20150005494
2015-01-01

Processes for preparing indoles

#64
20140371461
2014-12-18

Process for producing N-(hetero)arylazoles

#65
20140364585
2014-12-11

Immunoconjugates, compositions for making them, and methods of making and use

#66
20140361259
2014-12-11

Arylamine-based compound and organic light emitting diode comprising the same

#67
20140296524
2014-10-02

Halogenated compounds for photodynamic therapy

#68
20140296511
2014-10-02

Halogenated compounds for photodynamic therapy

#69
20140243534
2014-08-28

Halogenated compounds for Photodynamic therapy

#70
20140241989
2014-08-28

Imaging agents, process for the preparation thereof and pharmaceutical compositions containing same

#71
20140179732
2014-06-26

Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors

#72
20140171336
2014-06-19

Methods and kits using extended rhodamine dyes

#73
20140094608
2014-04-03

Modified carbocyanine dyes and their conjugates

#74
20140066479
2014-03-06

Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators

#75
20140048784
2014-02-20

Biscarbazole derivative and organic electroluminescent element using same

#76
20140031524
2014-01-30

Luminescence quenching compounds

#77
20130331424
2013-12-12

Antimicrobial compounds, compositions and methods of use thereof

#78
20130261118
2013-10-03

Compounds for Alzheimer's disease

#79
20130231604
2013-09-05

Halogenated compounds for photodynamic therapy

#80
20130230465
2013-09-05

Benzocyanine compounds

#81
20130186468
2013-07-25

Photoelectric conversion device and photoelectric conversion device dye, and compound

#82
20130129631
2013-05-23

Fluorescent probe for imaging lymph nodes

#83
20130059879
2013-03-07

Small molecule inhibitors of PFKFB3 and glycolytic flux and their methods of use as anti-cancer therapeutics

#84
20130052130
2013-02-28

Branched Discreet PEG Constructs

#85
20130020561
2013-01-24

Dibenzo[c,g]carbazole compound, light-emitting element, light-emitting device, display device, lighting device and electronic device

#86
20120321563
2012-12-20

Carbonic anhydrase targeting agents and methods of using same

#87
20120301490
2012-11-29

Immunoconjugates, compositions for making them, and methods of making and use

#88
20120288871
2012-11-15

Modified carbocyanine dyes and their conjugates

#89
20120225873
2012-09-06

Compounds for Alzheimer's disease

#90
20120138789
2012-06-07

Phosphonium-based ionic liquids and uses

#91
20120135885
2012-05-31

Methods and kits using extended rhodamine dyes

#92
20120123109
2012-05-17

Luminescence quenching compounds

#93
20120077986
2012-03-29

Preparation of anticancer-active tricyclic compounds via alkyne coupling reaction

#94
20120045851
2012-02-23

LABELS, THEIR PRODUCTION PROCESS AND THEIR USES

#95
20110309348
2011-12-22

Organic light-emitting device

#96
20110280890
2011-11-17

PRODRUGS OF CC-1065 ANALOGS

#97
20110262354
2011-10-27

CYANINE-CONTAINING COMPOUNDS FOR CANCER IMAGING AND TREATMENT

#98
20110207767
2011-08-25

CC-1065 analogs and their conjugates

#99
20110171678
2011-07-14

Modified carbocyanine dyes and their conjugates

#100
20110159483
2011-06-30

Cyanine compounds, compositions including these compounds and their use in cell analysis

#101
20110143387
2011-06-16

Highly water-soluble, cationic luminescent labels

#102
20110124510
2011-05-26

METHODS OF LABELING POLYNUCLEOTIDE WITH DIBENZORHODAMINE DYES

#103
20110118303
2011-05-19

Compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these

#104
20110112163
2011-05-12

CBI derivatives subject to reductive activation

#105
20110081294
2011-04-07

Contrast agent for photoacoustic imaging and photoacoustic imaging method

#106
20110057177
2011-03-10

Organic light emitting device

#107
20110053282
2011-03-03

Methods and kits using extended rhodamine dyes

#108
20110049494
2011-03-03

Heteroarylamine compound and organic light-emitting device including the same

#109
20110049490
2011-03-03

Heterocyclic compound and organic light-emitting device including the same

#110
20110049487
2011-03-03

Heteroarylamine compound and organic luminescence device using the same

#111
20110008373
2011-01-13

PRODRUGS OF CC-1065 ANALOGS

#112
20100331543
2010-12-30

Cyanine dyes and their applications as luminescence quenching compounds

#113
20100304074
2010-12-02

INDOLIUM COMPOUND AND OPTICAL RECORDING MATERIAL CONTAINING THE SAME

#114
20100227108
2010-09-09

Bridged cyanine compound and optical recording material using the same

#115
20100210658
2010-08-19

Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators

#116
20100197937
2010-08-05

Compound, probe containing the novel compound, and fluorescence-imaging contrast agent containing the novel compound or the probe

#117
20100196319
2010-08-05

4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections

#118
20100184975
2010-07-22

COMPOUNDS FOR ALZHEIMBER'S DISEASE

#119
20100173114
2010-07-08

OPTICAL RECORDING MEDIUM AND AZACYANINE DYE

#120
20100003445
2010-01-07

Cyanine compound and optical filter and optical recording material containing same

#121
20100003196
2010-01-07

Fluorescent membrane intercalating probes and methods for their use

#122
20090318668
2009-12-24

Water-soluble CC-1065 analogs and their conjugates

#123
20090304583
2009-12-10

PATHOLOGICAL TISSUE DETECTION AND TREATMENT EMPLOYING TARGETED BENZOINDOLE OPTICAL AGENTS

#124
20090281158
2009-11-12

Prodrugs of CC-1065 analogs

#125
20090269541
2009-10-29

Optical recording material, chalcone type compounds and metal complexes

#126
20090263327
2009-10-22

MINIMALLY INVASIVE PHYSIOLOGICAL FUNCTION MONITORING AGENTS

#127
20090124651
2009-05-14

CATECHOLAMINE DERIVATIVES AND PRODRUGS THEREOF

#128
20090082368
2009-03-26

METHODS OF MODULATING NEUROTROPHIN-MEDIATED ACTIVITY

#129
20090076278
2009-03-19

Methine dyes and uses of the same

#130
20090068751
2009-03-12

Methods of labelling polynucleotides with dibenzorhodamine dyes

#131
20090062324
2009-03-05

Catecholamine derivatives and prodrugs thereof

#132
20090035810
2009-02-05

Modified carbocyanine dyes and their conjugates

#133
20090035809
2009-02-05

Modified carbocyanine dyes and their conjugates

#134
20090028821
2009-01-29

Prodrugs of CC-A1065 analogs

#135
20090018141
2009-01-15

Kinase inhibitors, compositions thereof, and methods of use therewith

#136
20080318336
2008-12-25

Labels, their production process and their uses

#137
20080308149
2008-12-18

Squarylium dye, method of producing the same, photoelectric conversion element containing the dye, and solid-state imaging device

#138
20080281102
2008-11-13

Methods and compounds for preparing CC-1065 analogs

#139
20080260685
2008-10-23

Prodrugs of CC-1065 analogs

#140
20080249135
2008-10-09

Compounds for alzheimer's disease

#141
20080226860
2008-09-18

CYANINE DYES AND USE THEREOF

#142
20080214597
2008-09-04

Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors

#143
20080125455
2008-05-29

Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, Receptor ligands

#144
20080119442
2008-05-22

Nitrobenzindoles and their use in cancer therapy

#145
20080114048
2008-05-15

Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators

#146
20080114018
2008-05-15

Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands

#147
20080090858
2008-04-17

Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands

#148
20080085925
2008-04-10

Sulfonyltetrahydro-3H-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands

#149
20080081912
2008-04-03

Near-infrared absorptive image-forming composition, ink and electrophotographic toner using the same, and inkjet-recording method, electrophotographic-recording method and near-infrared-ray-reading method using those

#150
20080076188
2008-03-27

Luminescent compounds

#151
20080048155
2008-02-28

Filter and Cyanine Compound

#152
20070269373
2007-11-22

Hydrophilic light absorbing compositions for determination of physiological function in critically ill patients

#153
20070269368
2007-11-22

Hydrophilic light absorbing compositions for determination of physiological function in critically ill patients

#154
20070232805
2007-10-04

Modified carbocyanine dyes and their conjugates

#155
20070178512
2007-08-02

Modified carbocyanine dyes and their conjugates

#156
20070178511
2007-08-02

MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES

#157
20070173535
2007-07-26

Oxadiazoles having antiproliferative activity

#158
20070161669
2007-07-12

Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatment

#159
20070135346
2007-06-14

Prodrugs of CC-1065 analogs

#160
20070128115
2007-06-07

Pathological tissue detection and treatment employing targeted benzoindole optical agents

#161
20070105889
2007-05-10

Condensed indoline derivatives and their use as 5-HT, in particular 5-HT, receptor ligands

#162
20070099981
2007-05-03

Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands

#163
20070099980
2007-05-03

Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands

#164
20070099210
2007-05-03

Methods of Labelling Polynucleotides with Dibenzorhodamine Dyes

#165
20070009977
2007-01-11

Kinase-directed, activity-based probes

#166
20070003873
2007-01-04

Bis (indolestyryl) compound and high density recording media utilizing the same

#167
20060286483
2006-12-21

Cyanine compounds, optical recording materials and optical recording media

#168
20060229311
2006-10-12

Isatine derivatives with neurotrophic activity

#169
20060223076
2006-10-05

Cyanine dyes and their applications as luminescence quenching compounds

#170
20060211074
2006-09-21

Kinase-directed, activity-based probes

#171
20060199949
2006-09-07

Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods

#172
20060199223
2006-09-07

Chemiluminescent compounds and their use

#173
20060193780
2006-08-31

Fluorescent membrane intercalating probes

#174
20060116415
2006-06-01

Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators

#175
20060105257
2006-05-18

Indolenine compound, near infrared absorber, and toner containing the same

#176
20060099638
2006-05-11

Modified carbocyanine dyes and their conjugates

#177
20060051791
2006-03-09

Methods of labelling polynucleotides with dibenzorhodamine dyes

#178
20060014964
2006-01-19

Bicyclic and tricyclic amines as modulators of chemokine receptor activity

#179
20060009462
2006-01-12

Prodrugs of CC-1065 analogs

#180
20060004188
2006-01-05

Intermediates and the synthesis of modified carbocyanine dyes and their conjugates

#181
20050197380
2005-09-08

Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands

#182
20050192334
2005-09-01

Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands

#183
20050187282
2005-08-25

Condensed indoline derivatives and their use as 5HT, in particular 5HT, receptor ligands

#184
20050163715
2005-07-28

Dynamic organ function monitoring agents

#185
20050148651
2005-07-07

Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3-[ring fused indol-5-yl-(amine-derived)] compounds and analogues thereof, and to products obtained therefrom

#186
20050124682
2005-06-09

Substituted cyclic compounds

#187
20050101596
2005-05-12

Sulfonyltetrahydro-3H-benzo(E)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands

#188
20050059729
2005-03-17

Substituted cyclic compounds

#189
20050059675
2005-03-17

Benzoindoline compounds

#190
20050054709
2005-03-10

3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptideYreceptors ligands useful in the treatment of obesity and other disorders

#191
20050032860
2005-02-10

CBI analogs of CC-1065 and the duocarmycins

#192
20050031542
2005-02-10

Pathological tissue detection and treatment employing targeted optical agents

#193
20050027130
2005-02-03

Methods and kits using extended rhodamine dyes

#194
20050026987
2005-02-03

CBI analogues of the duocarmycins and CC-1065

#195
20050014700
2005-01-20

Cbi analogues of cc-1065 and the duocarmycins